Chlud K, Kaik B, Pangerl S
Arzneimittelforschung. 1978;28(7):1200-1.
40 patients with classical or definite rheumatoid arthritis were included in a double blind trial to assess efficacy and side effects of indometacin (n = 20) versus glucametacin (n = 20). In a daily dose of 420 mg glucametacin proved to be equally potent to 150 mg indometacin daily in its anti-inflammatory activity but showed fewer side effects.
40例典型或确诊的类风湿性关节炎患者被纳入一项双盲试验，以评估消炎痛（n = 20）与葡甲胺（n = 20）的疗效和副作用。每日剂量为420毫克的葡甲胺在抗炎活性方面被证明与每日150毫克的消炎痛同样有效，但副作用较少。
